INTRODUCTION {#S1}
============

The pyramidal motor system in humans directs voluntary movement. In particular, long cortical neurons that extend from layer V of the cerebral cortex into the spinal cord enable skilled limb mobility ([@R4]). The maintenance of these corticospinal neurons depends heavily on axonal transport of proteins, lipids, organelles, and other vesicular carriers. Thus, it is perhaps unsurprising that numerous regulators of membrane trafficking and organelle dynamics have been implicated in neurodegenerative disease ([@R42]; [@R33]). Among inherited neuropathies, hereditary spastic paraplegias (HSPs) and hereditary motor and sensory neuropathies (HMSNs) are the most common, collectively affecting hundreds of thousands of individuals worldwide ([@R7]; [@R43]). Despite their prevalence and severity, specific pathomechanisms underlying most of these disorders remain unknown. Nevertheless, the genetic diversity of HSPs provides an opportunity to delineate biochemical pathways that contribute to lifelong axon function.

With recent advances in whole-genome and exome sequencing technologies, there has been a surge in the identification of mutations that contribute to the development of peripheral neuropathies. Using this approach, we and others have demonstrated that point mutations in tropomyosin receptor kinase fused gene (TFG) (also known as SPG57) contribute to the pathology of HSPs, HMSNs, and amyotrophic lateral sclerosis (ALS) ([@R14]; [@R3]; [@R18]; [@R48]). However, in none of these cases is it clear how the mutations lead to axonopathy. Based on functional and localization studies, TFG plays an important role in maintaining the integrity of the early secretory pathway ([@R45]; [@R16]; [@R11]; [@R22]). In the absence of TFG, subdomains on the endoplasmic reticulum (ER) that produce COPII-coated transport carriers separate away from ER-Golgi intermediate compartments (ERGICs), slowing the export of secretory cargoes from the ER and triggering an ER stress response ([@R16]). Additionally, the organization of the ER is impaired following TFG depletion, as is the normal distribution of mitochondria in fibroblasts ([@R45]; [@R16]). Recently, the effect of overexpressing a mutant form of TFG implicated in HSP (p.R106C) was assessed in cultured murine neurons, which revealed a reduction in the size of mitochondria in neurites ([@R12]). Together, these data suggest that the pathogenicity of the TFG (p.R106C) mutation may relate to an unidentified role in regulating mitochondrial function, although the artificial nature of overexpressing TFG or depleting it using small interfering RNAs (siRNAs) poorly simulates the disease condition.

A more physiologically relevant alternative to defining the impact of mutations in neurons has evolved with the development of stem cell technologies. Tissue samples acquired from patients are now routinely cultured and reprogrammed in vitro to generate induced pluripotent stem cells (iPSCs), which can be differentiated toward a number of distinct fates, including the telencephalic glutamatergic cortical neurons that are affected in HSP ([@R41]; [@R8]). Previous studies showed that patient-derived fibroblasts harboring the pathogenic SPG3A (p.P342S) mutation could be reprogrammed and differentiated into forebrain neurons, enabling the identification of neurite outgrowth defects and reduced mitochondrial transport in mutant cells ([@R8]). Although this approach is promising, it remains to be determined whether the observed phenotypes are a direct result of the SPG3A (p.P342S) mutation alone or a combination of the hypomorphic SPG3A allele with other genetic variants in the background used. More recently, clustered regularly interspaced short palindromic repeats (CRISPR)-mediated genome editing has been used to correct mutations implicated in disease and determine their relevance to phenotypes observed ([@R47]; [@R19]). Nevertheless, the use of patient-derived iPSCs introduces genetic variability, which can complicate the interpretation of data collected.

More than 70 genetic loci have been linked to the various forms of HSP, with most gene products identified possessing putative roles in axon pathfinding, axon myelination, organelle dynamics, motor-dependent transport, and/or lipid metabolism ([@R20]). In the majority of cases, there is minimal information regarding the functional consequences of the specific mutations identified. Here, we use a combination of structural biology, stem cell technology, and high-resolution imaging to define the impact of the TFG (p.R106C) mutation. Our findings demonstrate that the mutation impairs TFG complex assembly, which interferes with its function in the early secretory pathway, promotes ER stress, and disrupts the ability of axons to selfassociate. These data suggest that the long axons of the corticospinal tract are particularly susceptible to relatively modest deficits in protein secretion and highlight this pathway as a potential therapeutic target for axonopathies that affect peripheral motor function.

RESULTS {#S2}
=======

A Clinically Relevant Mutation in TFG Disrupts Its Ability to Form Compact Ring Complexes {#S3}
-----------------------------------------------------------------------------------------

Mutations within the TFG coiled-coil domain (amino acids 97--124) have been suggested to impair its function and underlie early-onset forms of HSP ([@R3]; [@R12]). To gain an understanding of the mechanism by which such mutations affect TFG, we conducted a series of biochemical and structural studies comparing the recombinant wildtype protein with the TFG (p.R106C) mutant, which has been identified in numerous HSP patients. Since the C terminus of TFG is intrinsically disordered ([@R16]), we focused our attention on the TFG N terminus (amino acids 1--193), which includes a PB1 domain (amino acids 10--91), as well as the coiled-coil domain, followed by a serine/threonine-rich region ([Figure 1A](#F1){ref-type="fig"}). We showed previously that the TFG (p.R106C) mutation modestly alters the hydrodynamic properties of TFG ([@R3]), but its specific impact on the helical character of the coiled-coil domain remains unclear. To address this issue, we first conducted circular dichroism (CD) spectroscopy on various TFG isoforms. These studies revealed no significant differences in the helicity of the TFG (p.R106C) mutant as compared to wildtype TFG ([Figure 1B](#F1){ref-type="fig"}). In contrast, mutation of six key leucine residues to valine (L97V, L105V, L109V, L112V, L120V, and L123V), which is predicted to completely disorder the heptad repeat pattern of the coiled-coil domain, resulted in a dramatic change in the circular dichroism spectrum, consistent with a loss in overall helicity ([Figure 1B](#F1){ref-type="fig"}). We next examined the hydrodynamic properties of the isolated coiled-coil domain of wild-type TFG and the TFG (p.R106C) mutant. Based on a combination of size exclusion chromatography and multiangle light scattering, both proteins exhibited a similar ability to homo-oligomerize *in vitro* (Figures [1C](#F1){ref-type="fig"} and[1D](#F1){ref-type="fig"}). In contrast, mutation of the six leucine residues within the coiled-coil domain to valine blocked self-association, resulting in the presence of monodisperse monomers of approximately 26 ± 3 kDa in mass (predicted molecular weight of 20.1 kDa) (Figures [1C](#F1){ref-type="fig"} and[1D](#F1){ref-type="fig"}). Together, these data indicate that the TFG (p.R106C) mutation does not fully disrupt or unfold the coiled-coil domain.

To gain further insight into the impact of the TFG (p.R106C) mutation, we next used small-angle X-ray scattering (SAXS), a solution-based technique that can report on the conformation of biological macromolecules ([@R27]). We used a smaller fragment of TFG for these studies (amino acids 1--138) to facilitate ab initio modeling. SAXS analysis of wild-type TFG produced consistent scattering profiles over several protein concentrations (150--750 mM) ([Figure 1E](#F1){ref-type="fig"}), and the excluded particle (Porod) volume was used to estimate its mass to be 130 kDa, consistent with the predicted mass of 126.1 kDa for a TFG octamer, based on amino acid composition. From these data, we also determined the radius of gyration (R~g~) to range from 35.1 ± 0.1 Å (750 mM) to 38.0 ± 0.3 Å(150 mM), depending on protein concentration ([Figures S1A--S1C](#SD1){ref-type="supplementary-material"}). Similarly, the maximal inter-atomic distance (D~max~) was concentration dependent, ranging from 94 to 120 Å , with higher compaction of the octamer observed at elevated protein concentrations ([Figure S1C](#SD1){ref-type="supplementary-material"}). SAXS envelopes were defined ab initio based on the scattering profiles. Seventeen independent models were aligned and averaged (based on two different protein concentrations), with a mean normalized spatial discrepancy (NSD) of 0.83, to reveal an octameric ring-like structure comparable in organization to that defined previously by three-dimensional single-particle electron microscopy ([Figure 1F](#F1){ref-type="fig"}). The extensive similarity of the envelope with our prior electron microscopy-based analysis of TFG validates the use of SAXS for studying the impact of the TFG (p.R106C) mutation on the conformation of the octameric complex ([Figure S1D](#SD1){ref-type="supplementary-material"}).

SAXS analysis of TFG (p.R106C) produced consistent scattering profiles over the same protein concentrations examined for the wild-type protein (150--750 mM) ([Figure 1G](#F1){ref-type="fig"}). However, in contrast to the wild-type protein, TFG (p.R106C) exhibited significantly higher R~g~ values (41.5 ± 0.9 Å , 150 mM; 41.3 ± 1.2 Å, 375 mM; 41.6 ± 1.0 Å , 750 mM) that did not vary based on protein concentration ([Figures S1E and S1F](#SD1){ref-type="supplementary-material"}). The D~max~ of TFG (p.R106C) was similarly concentration independent (on average, 141 ± 4 Å ), suggesting a less compact organization relative to the wildtype protein ([Figure S1C](#SD1){ref-type="supplementary-material"}). Based on the scattering profiles collected at two protein concentrations, SAXS envelopes were defined ab initio. Twenty independent models were aligned and averaged, with a mean NSD of 0.90, to reveal a larger, more asymmetric assembly, as compared to the wild-type protein complex ([Figure 1H](#F1){ref-type="fig"}). Collectively, these data suggest that the TFG (p.R106C) mutation impairs the function of the coiled-coil domain to generate compact octameric ring-like complexes.

To investigate this idea further, we examined the conformation of the TFG N terminus lacking the entire coiled-coil domain (amino acids 1--96) using SAXS. Based on hydrodynamic studies and multiangle light scattering, this region of TFG formed oligomers in solution ([Figure S1G](#SD1){ref-type="supplementary-material"}), consistent with the presence of a type I/II PB1 domain ([@R39]). SAXS analysis of this TFG fragment produced consistent scattering profiles irrespective of protein concentration (450--900 mM), and we determined the radius of gyration (R~g~) to be 36.1 ± 0.2 Å, with a D~max~ of 105 Å ([Figures S1H and S1I](#SD1){ref-type="supplementary-material"}). Twenty independent models were aligned and averaged (based on two different protein concentrations), with a mean NSD of 0.90, to reveal an oligomer in the shape of a curved tube ([Figure S1J](#SD1){ref-type="supplementary-material"}). This conformation closely resembles that of the intact TFG N terminus harboring its coiled-coil domain, except that key contacts necessary to bring together the ring-like structure appear to be absent. These data support the idea that the coiled-coil domain plays an important role in regulating TFG complex assembly to generate compact ring structures.

To directly visualize differences in the wild-type and mutant TFG complexes, we used single-particle electron microscopy. As described previously ([@R16]), wild-type TFG typically forms ring-like structures that are approximately 10--11 nm in diameter, as visualized under negative stain ([Figure 2A](#F2){ref-type="fig"}). In contrast, under identical buffer conditions (50 mM HEPES, pH 7.6; 100 mM NaCl), TFG (p.R106C) complexes exhibited a more heterogeneous arrangement of protomers and largely failed to form compact ring structures ([Figure 2B](#F2){ref-type="fig"}). Notably, the predicted isoelectric point for TFG is 5.5. We therefore dialyzed the wild-type TFG complexes into a buffer with this pH and observed that they exhibited reduced aggregation and improved staining homogeneity. Under these conditions, the propensity of TFG (p.R106C) complexes to form ring structures was increased ([Figure 2C](#F2){ref-type="fig"}), consistent with the idea that the mutant protein is deficient for normal assembly but that the equilibrium can be shifted by lowering the pH. Nevertheless, although the TFG (p.R106C) mutant appeared capable of forming ring-like structures under these buffer conditions, we found that individual particles appeared more disorganized and distorted as compared to the wild-type protein ([Figure 2D](#F2){ref-type="fig"}). In contrast, mutation of six leucine residues to valine within the coiled-coil domain blocked TFG ring assembly ([Figure S2A](#SD1){ref-type="supplementary-material"}). Collectively, our findings strongly suggest that the TFG (p.R106C) mutation specifically perturbs the normal conformation of TFG ring structures without having a dramatic effect on the ability of TFG protomers to self-associate.

To determine whether the specific presence of a positively charged residue at amino acid 106 in TFG is important for normal ring assembly, we additionally examined a TFG (p.R106K) mutant. We found that this mutation neither impaired the ability of the coiled-coil domain to self-associate, nor did it perturb the overall architecture of TFG ring complexes, even at neutral pH ([Figures S2B and S2C](#SD1){ref-type="supplementary-material"}). However, the clinically relevant TFG (p.R22W) mutation, which is located within the PB1 domain and also underlies an early-onset form of complicated HSP ([@R9]), caused a similar perturbation in ring assembly as compared to the TFG (p.R106C) mutation ([Figure S2D](#SD1){ref-type="supplementary-material"}), suggesting that proper folding and self-association of the PB1 domain is also critical for TFG complex formation. Consistent with this idea, examination a TFG (p.K14A) mutant, which impairs the ability of type I/II PB1 domains to self-associate ([@R39]), strongly inhibited TFG ring assembly under all conditions tested ([Figure S2E](#SD1){ref-type="supplementary-material"}). Together, these data underscore the importance of both the PB1 and coiled-coil domains in assembling TFG complexes with a functional conformation.

To determine whether the altered conformation of TFG (p.R106C) affects its distribution in cells, we initially used a replacement strategy in which endogenous TFG is depleted using an siRNA targeting its 3*'*-UTR and an exogenous, doxycycline inducible isoform is expressed after directed transgene insertion into the "safe harbor" AAVS1 locus ([@R16]; [@R28]). Using this system, we found that wildtype TFG accumulates with markers of COPII transport at the ER/ERGIC interface in human hTERT-immortalized RPE-1 cells ([Figures S2F and S2G](#SD1){ref-type="supplementary-material"}). Similarly, a mutation in the coiled-coil domain that maintains positive charge at residue 106, TFG (p.R106K), failed to perturb its distribution in cells ([Figures S2F and S2G](#SD1){ref-type="supplementary-material"}). In contrast, at similar levels of expression ([Figure S2H](#SD1){ref-type="supplementary-material"}), TFG (p.R106C) exhibited reduced accumulation at the ER/ ERGIC interface, as did another mutant that neutralizes positive charge at residue 106, TFG (p.R106A) ([Figures S2G and S2I](#SD1){ref-type="supplementary-material"}). Additionally, the TFG (p.R106C and p.R106A) mutations led to the appearance of more TFG-positive structures that failed to exhibit staining for COPII components, including several enlarged foci that exhibited high levels of the mutant TFG proteins ([Figures S2I and S2J](#SD1){ref-type="supplementary-material"}) Mutation of six leucine residuces to valine within the coiled-coil domain resulted in a dramatic redistribution of TFG away from the ER/ERGIC interface, further highlighting the importance of this domain to proper TFG localization ([Figure S2K](#SD1){ref-type="supplementary-material"}).

The TFG (p.R106C) Mutation Impairs Secretory Protein Trafficking and Elevates ER Stress {#S4}
---------------------------------------------------------------------------------------

To establish a more physiologically relevant system to define the impacts of the TFG (p.R106C) mutation, we leveraged CRISPR technology to incorporate two nucleotide changes into well-characterized IMR90--4 human iPSCs. The first edit (c.316C\>T) corresponds to the mutation found in HSP patients, while the second (c.321A\>C) is silent, but introduces a novel restriction site to facilitate the identification of genome-edited cells. We screened a total of 300 edited clonal cell lines by PCR and restriction digest after single-cell sorting and identified 25 candidates for direct sequencing. Of these, we selected three homozygous clones (clones A--C), three heterozygous clones (clones D--F), and a control clone that was homozygous for the c.321A\>C silent mutation, but failed to incorporate a change at nucleotide 316 (clone G) for further analysis ([Figure 3A](#F3){ref-type="fig"}). Upon passaging, each clone exhibited a similar morphology as compared to IMR90--4, growing as individual colonies, and all stained positively for pluripotency markers, including Nanog, SSEA4, and Oct4 (Figures [3B](#F3){ref-type="fig"} and [S3A](#SD1){ref-type="supplementary-material"}). Additionally, karyotype analysis revealed no discernable defects in any of the clones following CRISPRmediated genome editing (Figures [3C](#F3){ref-type="fig"} and [S3B](#SD1){ref-type="supplementary-material"}).

We and others have shown previously that TFG is expressed ubiquitously in mammals ([@R3]; [@R21]). To determine the impact of the TFG (p.R106C) mutation, we differentiated each human iPSC clone toward a variety of cell fates. Given the importance of TFG at the ER/ERGIC interface, we initially generated tyrosinase-positive melanocytes (ectodermal lineage) and vimentin-positive fibroblasts (mesodermal lineage), both of which are amenable to assays for secretory pathway function ([Figure S4A](#SD1){ref-type="supplementary-material"}). Based on immunoblot analysis, TFG expression levels were not affected by presence of the p.R106C mutation in either cell type ([Figures S4B and S4C](#SD1){ref-type="supplementary-material"}). Immunofluorescence staining revealed that TFG (p.R106C) expressed at endogenous levels accumulated normally at the ER/ERGIC interface in homozygous, genome-edited fibroblast clones (Figures [4A](#F4){ref-type="fig"}, [4B](#F4){ref-type="fig"}, and [S4D](#SD1){ref-type="supplementary-material"}). However, in differentiated melanocytes, TFG (p.R106C) exhibited diminished co-localization with COPII transport carriers, relative to wild-type TFG (Figures [4C](#F4){ref-type="fig"} and[4D](#F4){ref-type="fig"}). Instead, we consistently observed numerous structures, which labeled positively for TFG, but lacked other components of the early secretory pathway. Moreover, we found that the levels of TFG (p.R106C) at the ER/ERGIC interface were modestly, but significantly reduced as compared to wild-type TFG in control melanocytes ([Figure S4D](#SD1){ref-type="supplementary-material"}). Based on two-hybrid analysis, this was not due to a defect in the ability of TFG to associate with the COPII component Sec23 ([Figure S4E](#SD1){ref-type="supplementary-material"}), which we showed previously to be critical for TFG accumulation at the ER/ERGIC interface ([@R11]). Together, these data indicate that the TFG (p.R106C) mutation affects its distribution, but only in a cell-type-specific manner.

To define potential impacts on early secretory pathway function, we transduced iPSC-derived melanocytes with a retrovirus encoding a GFP-tagged, temperature-sensitive form of vesicular stomatitis virus G protein (VSVG) (ts045), which misfolds and accumulates in the ER at 40oC, but folds properly and is capable of ER exit upon shift to 32oC ([@R25]). Cells expressing low levels of VSVG were imaged live following temperature shift. In control melanocytes, VSVG moved rapidly from the ER and began to accumulate in the perinuclear Golgi within 5--7 min ([Figure 5A](#F5){ref-type="fig"}). Although the average timing of VSVG appearance at the Golgi did not differ significantly in melanocytes expressing TFG (p.R106C), we observed prolonged accumulation of the cargo at punctate structures throughout the peripheral ER in mutant cells relative to controls, suggesting a delay during transport through the early secretory pathway (Figures [5A](#F5){ref-type="fig"} and[5B](#F5){ref-type="fig"}). Specifically, in contrast to control melanocytes, which exhibited only transient elevations in VSVG intensity at punctate structures prior to Golgi accumulation, VSVG levels accumulated to higher levels at such sites and persisted for a longer period of time in melanocytes expressing TFG (p.R106C) (Figures [5A](#F5){ref-type="fig"} and[5B](#F5){ref-type="fig"}).

Defects in the kinetics of protein secretion are often associated with an elevated unfolded protein response (UPR) ([@R46]). To determine whether the TFG (p.R106C) mutation leads to an activation of ER stress sensors, we stably transduced iPSC-derived fibroblasts and melanocytes to express a luciferase-based reporter of XBP1 mRNA splicing ([@R15]). Control iPSC-derived cells exhibited negligible levels of luciferase luminescence, but treatment with a low concentration of tunicamycin, which leads to protein misfolding in the ER, resulted in an increase in XBP1 mRNA splicing ([Figure S4F](#SD1){ref-type="supplementary-material"}). Melanocytes exhibited a particularly strong ER stress response, as compared to fibroblasts. Strikingly, even in the absence of tunicamycin, cells expressing the homozygous TFG (p.R106C) mutation also exhibited elevated XBP1 mRNA splicing ([Figure S4F](#SD1){ref-type="supplementary-material"}), consistent with our finding that these cells show a kinetic delay in protein secretion from the ER. Since XBP1 mRNA splicing is largely regulated by the IRE1 ER stress sensor, we directly examined its activity in control and TFG (p.R106C) melanocytes by assessing the phosphorylation state of its kinase activation loop ([@R26]). Immunoblot analysis confirmed that cells expressing the homozygous TFG (p.R106C) mutation exhibit constitutive activation of the IRE1 branch of the UPR ([Figure 5C](#F5){ref-type="fig"}).

To determine whether heightened IRE1 activity sensitizes TFG (p.R106C)-expressing cells to additional forms of ER stress, we examined cargo transport to the Golgi following treatment and washout of brefeldin A (BFA), a fungal metabolite that inhibits guanine nucleotide exchange activity on several Arf-type GTPases, leads to the redistribution of integral membrane Golgi proteins to the ER, and dramatically increases ER stress signaling ([@R13]; [@R5]). For this assay, we transfected iPSC-derived fibroblasts and melanocytes with a GFP fusion to the transmembrane Golgi enzyme mannosidase II (ManII). In the absence of BFA, ManII accumulated at the Golgi in all clones, irrespective of the TFG isoform expressed, and addition of BFA resulted in the expected redistribution of ManII to the ER ([Figure 5D](#F5){ref-type="fig"}). Within 120 min after BFA removal, more than 80% of control fibroblasts exhibited complete re-accumulation of ManII at the Golgi (Figures [5D](#F5){ref-type="fig"} and[5E](#F5){ref-type="fig"}). In contrast, fibroblasts that were homozygous for the TFG (p.R106C) mutation largely retained ManII in the ER at this time point (Figures [5D](#F5){ref-type="fig"} and[5E](#F5){ref-type="fig"}). After an extended period of washout, ManII was ultimately able to reach the Golgi in the mutant fibroblasts, again indicating that the TFG (p.R106C) mutation impairs the kinetics of protein secretion but does not block it ([Figure 5D](#F5){ref-type="fig"}). Similarly, melanocytes harboring the homozygous TFG (p.R106C) mutation also exhibited a delay in ManII trafficking to the Golgi following BFA washout ([Figure 5F](#F5){ref-type="fig"}). Together, our findings suggest that hypomorphic mutations in TFG, which disrupt its ring-like conformation, impact protein trafficking and the ER stress response in multiple cell lineages.

The Distribution of TFG in Cortical Neurons Is Disrupted by the p.R106C Mutation {#S5}
--------------------------------------------------------------------------------

Patients with the TFG (p.R106C) mutation exhibit progressive loss of gait and motor control, suggesting a particularly important function for TFG in neurons of the corticospinal tract ([@R3]). We therefore used control and genome-edited iPSCs to generate Tbr1- and Tau-positive glutamatergic cortical neurons using established protocols ([Figures S5A and S5B](#SD1){ref-type="supplementary-material"}). The timing of differentiation was indistinguishable between control and TFG (p.R106C) mutant cells ([Figure S5C](#SD1){ref-type="supplementary-material"}), and similar to iPSC-derived fibroblasts and melanocytes, the overall levels of TFG in differentiated cortical neurons were not affected by the presence of the p.R106C mutation ([Figure S5D](#SD1){ref-type="supplementary-material"}). qPCR analysis further indicated that expression of TFG was also unaffected by presence of the mutation ([Figure S5E](#SD1){ref-type="supplementary-material"}). Additionally, wholecell patch-clamp recordings revealed no significant differences in synaptic activity or the membrane properties of homozygous TFG (p.R106C) neurons as compared to control ([Figures S6A--S6C](#SD1){ref-type="supplementary-material"}). These studies suggest that the TFG (p.R106C) mutation does not inhibit the differentiation of cortical neurons nor their spontaneous electrical activity *in vitro*.

We next examined early secretory pathway organization in iPSC-derived neurons, focusing on the distribution of markers associated with the Golgi apparatus and formation of COPIIcoated transport carriers. Using antibodies directed against GM130, a cis-Golgi matrix tethering protein, we found that the Golgi was largely limited to cell bodies in control neurons, juxtaposed to the nucleus, and homozygous expression of TFG (p.R106C) failed to dramatically impact its distribution or morphology ([Figure S6D](#SD1){ref-type="supplementary-material"}). In contrast, the localization of TFG in the mutant neurons was perturbed, similar to what we observed in iPSC-derived melanocytes. Specifically, we found that TFG (p.R106C) was more poorly retained at the ER/ERGIC interface in cell bodies and exhibited a more diffuse distribution throughout neurons (Figures [6A](#F6){ref-type="fig"} and [S6D](#SD1){ref-type="supplementary-material"}). These data are consistent with the idea that the p.R106C mutation alters TFG localization, most prominently in cells of the ectodermal lineage. Based on a previous study, overexpression of TFG (p.R106C) in primary murine hippocampal neurons results in the fragmentation of mitochondria ([@R12]). The mechanistic basis of this effect is unknown. However, our findings in RPE-1 cells indicate that overexpressed TFG (p.R106C) exhibits an enhanced propensity to form enlarged aggregates (see [Figure S2I](#SD1){ref-type="supplementary-material"}), which contrasts the distribution of the mutant protein when expressed at endogenous levels, and may indirectly affect mitochondrial morphology. We therefore conducted measurements of mitochondrial volume in Tau-positive neurites following differentiation of genome-edited human iPSCs. Our analysis revealed no significant discrepancies between the control and TFG (p.R106C) mutant neurons ([Figure S6E](#SD1){ref-type="supplementary-material"}). We additionally analyzed mitochondrial motility and found no significant differences in the percentage of motile mitochondria, nor their average rate of movement in neurites ([Figure S6F](#SD1){ref-type="supplementary-material"}). Together, these data suggest that that presence of the TFG (p.R106C) mutation is unlikely to have a direct effect on mitochondrial dynamics, including fission/fusion events.

Recent studies have also suggested that lysosomal defects are commonly associated with several mutations underlying HSPs ([@R1]). We therefore immunostained control and TFG (p.R106C) mutant neurons with the late endosome/ lysosome marker LAMP-1 and measured the volumes of structures identified in cell bodies. Our analysis failed to demonstrate any differences in lysosome size or morphology between control and TFG (p.R106C) mutant neurons ([Figure S6G](#SD1){ref-type="supplementary-material"}), and we also failed to observe lysosome-enriched axonal swellings, as previously observed in mutant SPG4 patient-derived neurons ([@R8]; [@R1]). Similarly, changes in autophagic flux, which have been frequently associated with neurodegenerative diseases ([@R23]), were not detected in TFG (p.R106C) mutant neurons, as indicated by the relative levels of lipidated (LC3-II) versus non-lipidated (LC3-I) LC3 ([Figure S6H](#SD1){ref-type="supplementary-material"}).

TFG Functions to Promote Axon Bundling {#S6}
--------------------------------------

Previous work suggested that defects in ER structure/function caused by mutations in SPG3A (atlastin-1) contribute to neurodegenerative disease by impairing axon growth ([@R8]). To determine whether the TFG (p.R106C) mutation causes a similar effect, we generated iPSC-derived neurospheres and measured axon outgrowth following their transfer to coverslips. We found that homozygous neurons expressing TFG (p.R106C) extended axons to a similar length as observed in control neurons (Figures [6B](#F6){ref-type="fig"} and[6C](#F6){ref-type="fig"}). However, during these studies, we also noted that control axons rapidly form bundles after emerging from neurospheres ([Figure 6B](#F6){ref-type="fig"}). In contrast, neurons expressing TFG (p.R106C) failed to exhibit normal axon fasciculation (Figures [6B](#F6){ref-type="fig"} and[6D](#F6){ref-type="fig"}). We also examined iPSC-derived neurons expressing the dominant-acting SPG3A (p.P342S) mutation and found that axon bundling occurred normally ([Figure 6D](#F6){ref-type="fig"}). Together, these data suggest that TFG plays a distinct role from other regulators of ER function in axon maintenance.

Since our earlier studies suggested that the TFG (p.R106C) mutation causes an elevation in ER stress, we investigated the possibility that increased UPR signaling may affect the ability of axons to bundle. In an attempt to test this idea, we treated neurospheres with a low concentration of tunicamycin that was sufficient to activate IRE1, and examined neurite morphology over several days. Within 2 days of treatment, neurite outgrowth was found to be significantly impaired, and by day 5, neurites had largely undergone retraction and degeneration ([Figure S7](#SD1){ref-type="supplementary-material"}), preventing us from determining whether axon bundling was directly impacted. We therefore decided to explore alternative mechanisms by which the TFG (p.R106C) mutation might affect establishment or maintenance of axon contact.

Homotypic axon fasciculation is largely mediated by adhesion molecules that must be secreted to the surface of axonstoengage one another via extracellular domains ([@R44]). Based on our findings that cells only expressing TFG (p.R106C)exhibitdefectsincargotransportfromtheER,wespeculated that the defect in axon bundling may result from impaired trafficking of adhesion molecules. To address this possibility, we stained genome-edited iPSC-derived neurons using antibodies directed against a subset of calcium-dependent and calciumindependent cell adhesion molecules ([@R38]). As compared to controls, we found that the levels of cell surface L1CAM in particular were reduced in the axons of neurons expressing TFG (p.R106C), consistent with the idea that its transport to the cell surface was impaired (Figures [7A](#F7){ref-type="fig"} and[7B](#F7){ref-type="fig"}). Importantly, this change was not a result of diminished L1CAM expression ([Figure 7C](#F7){ref-type="fig"}). Instead, these data suggest that efficient membrane trafficking in the early secretory pathway plays a critical role in maintaining neuronal homeostasis, especially in the long corticospinal motor neurons that undergo degeneration in HSPs.

DISCUSSION {#S7}
==========

Over the past several years, it has become evident that ER homeostasis plays a critical role in maintaining neuronal health. Mutations in numerous factors that regulate ER structure and function have been linked to a variety of neurodegenerative diseases, potentially by affecting calcium signaling, lipid biosynthesis, membrane trafficking, and/or interorganellar communication ([@R4]; [@R10]). Based on our previous work demonstrating that TFG regulates protein transport at the ER/ERGIC interface ([@R45]; [@R16]; [@R11]), we hypothesized that TFG variants implicated in neurological disorders impair the secretion of biosynthetic cargoes. Here, we find that iPSC-derived cortical neurons homozygous for TFG (p.R106C) exhibit reduced levels of an important adhesion molecule at the surface of axons, which impedes their ability to self-associate. Based on post-mortem studies, loss of axon fasciculation within the corticospinal tract is commonly associated with motor neuropathies ([@R31]). This defect may contribute to reduced nerve conduction speed, which has been documented in several HSP patients harboring mutations in the TFG N terminus ([@R3]). Together, our findings highlight the importance of efficient secretory egress from the ER in maintaining proper neuronal function, especially in the long cortical neurons that extend into the spinal cord.

Our structural and biochemical studies indicate that pathological mutations in the TFG N terminus lead to conformational abnormalities in TFG complexes, which significantly affect their distribution, but only in certain cell types. Nonetheless, kinetic delays in protein secretion appear to be more widespread in cells expressing homozygous TFG (p.R106C). These findings suggest that the mutation in the TFG coiled-coil domain has at least two distinct effects, one of which is dependent on cell lineage, while the other is not. The distribution of a protein is often regulated by interacting partners, which may be differentially expressed in various tissues. For example, the membrane-associated protein CIP4 functions in the endocytic pathway in fibroblasts but regulates membrane protrusion in neurons and cancer cells, largely due to unique interactions in these different cell types ([@R32]). Similarly, cortical neurons may express specific factors that facilitate TFG localization but are only able to function appropriately when TFG complexes adopt their compact ring-like architecture. Based on this idea, it follows that homozygous TFG (p.R106C) individuals exhibit pronounced CNS phenotypes, but more limited perturbations in other tissues.

Independent of cell type, homozygous expression of TFG (p.R106C) slows protein export from the ER, which likely underlies the constitutive elevation in ER stress we observe in both iPSC-derived fibroblasts and melanocytes. At a mechanistic level, it remains unknown how the TFG (p.R106C) mutation causes this defect. One possibility is that the conformational change in TFG ring complexes impairs their ability to concentrate at the ER/ERGIC interface to promote outer COPII coat dissociation, which is a prerequisite for ER-derived transport carriers to tether and fuse with ERGIC membranes ([@R11]). Alternatively, the loosely assembled TFG (p.R106C) oligomers may not function optimally to organize COPII budding sites, which could preferentially affect the transport of bulky, high-molecular-weight cargoes ([@R22]). The retention of such cargoes could subsequently lead to additional consequences, including an elevation of ER stress ([@R30]). Importantly, elevated ER stress resulting from a deficit in protein secretion may also contribute to neurodegeneration ([@R35]). Several studies have shown that neuronal ER stress is a hallmark of Alzheimer's disease, Huntington's disease, synucleinopathies, ALS, and prion disease, although many of the models used are based on the overexpression of mutated genes identified in patient studies ([@R40]; [@R24]; [@R6]). Our findings here emphasize the danger of this approach, as ectopically overexpressed TFG (p.R106C) behaves differently in cells when compared to the mutant expressed at endogenous levels. Nevertheless, therapeutic strategies to reduce ER stress and the UPR have been used on several models of neurodegenerative disease with varying levels of success ([@R29]). Our data suggest that some HSPs may also respond to this approach, although improved animal models will be necessary to formally test this possibility.

Although we identified L1CAM as one particular cargo in neurons that seems to rely heavily on TFG function for efficient secretion, it is likely that other secretory proteins are similarly affected. Notably, L1CAM was one of the first genes implicated in the pathogenesis of HSP and mutations affecting it result in the most common form of X-linked HSP, often associated with the absence of L1CAM cell surface expression and impaired axonal adhesion ([@R20]; [@R2]; [@R34]). Patients expressing mutant isoforms of L1CAM typically exhibit thinning of the corpus callosum with early-onset leg spasticity, consistent with phenotypes observed in patients with mutations in TFG ([@R3]; [@R36]; [@R17]). Our data demonstrating a defect in axon fasciculation in iPSC-derived neurons expressing TFG (p.R106C) further support an intimate connection between TFG function and L1CAM cell surface expression. Considering the length of neurons in the corticospinal tract, even minor perturbations to L1CAM trafficking may affect bundling of distal axon segments, especially during neurite outgrowth. In contrast, a similarly modest reduction in ER export in a fibroblast or melanocyte would have a more limited impact on cell growth. Confirmation of this idea will require further studies in patients with TFG mutations or the development of an appropriate animal model.

EXPERIMENTAL PROCEDURES {#S8}
=======================

Recombinant Protein Expression and Purification {#S9}
-----------------------------------------------

All recombinant proteins were expressed using BL21(DE3)-T1R bacteria (Sigma-Aldrich) and purified initially using glutathione agarose beads (for GST-fusion proteins) or nickel affinity resin (polyhistidine-tagged proteins). Eluted or cleaved proteins were subsequently applied onto ion exchange and/or gel filtration columns for further purification ([@R16]). For circular dichroism spectroscopy, purified proteins were analyzed using a 0.1-cm path length quartz cell in 25 mM sodium phosphate (pH 7.2). Spectra were collected using a model 202SF circular dichroism spectrophotometer at 25C. For mass determination, proteins were examined by dynamic light scattering using a Wyatt mini-DAWN TREOS three-angle light-scattering detector coupled to a high-resolution size exclusion chromatography system. ASTRA software was used to calculate molecular mass ([@R37]).

SAXS Data Collection {#S10}
--------------------

Data were collected at sector 12-ID-B of the Advanced Photon Source (APS) at Argonne National Laboratory and obtained at a wavelength of 1.54 Å and a sample-detector distance of 4 m (small-angle) and 30 cm (wide-angle) resulting in a total momentum transfer range of 0.01 \< q \< 2.31 Å 1. Data were collected for buffer and protein at 25C for 2 min (APS), and buffer subtraction was adjusted for the excluded volume of the protein. The predicted scattering intensity at q = 0 Å 1 and the radius of gyration (R~g~) were determined by Guinier analysis ([@R27]) and compared between two to three concentrations to detect interparticle interference and concentration-dependent changes in conformation.

Single-Particle Electron Microscopy {#S11}
-----------------------------------

Purified proteins (4 μL) at a concentration of 0.01 mg/mL were placed on plasma-cleaned carbon-coated grids, washed with water, and stained with 2% uranyl formate as described previously ([@R16]). Imaging was conducted using an FEI Titan Krios transmission electron microscope operated at 120 keV and equipped with a Gatan Ultrascan 4,000 3 4,000 charge-coupled device (CCD) camera. Class averages were generated by reference-free alignment ([@R16]).

CRISPR-Mediated Genome Editing {#S12}
------------------------------

For CRISPR-mediated editing, iPSCs were electroporated with a plasmid encoding Cas9-GFP, a guide RNA targeting TFG (5'-GAAGTTCTATCAGTT CTCGA-3'), and a single-stranded oligonucleotide to incorporate the desired point mutations via homology directed repair. Cells were sorted using a BD FACSAria III cell sorter based on GFP fluorescence, and individual colonies were harvested after 1 week and moved to individual Matrigel-coated dishes. The incorporation of point mutations was confirmed following genomic DNA preparation, PCR amplification, and Sanger sequencing. For karyotype analysis, Giemsa banding was outsourced to WiCell Cytogenetics Laboratory. Stem cell maintenance and differentiation procedures are detailed in [Supplemental Experimental Procedures](#SD2){ref-type="supplementary-material"}.

Immunofluorescence and Confocal Microscopy {#S13}
------------------------------------------

For immunofluorescence analysis, cells were fixed using paraformaldehyde (4%) and stained using primary antibodies at a final concentration of 1 μg/mL, as described previously ([@R16]). Imaging was conducted on a swept-field confocal microscope using a Roper CoolSnap HQ2 CCD camera and a Nikon 603, 1.4 numerical aperture (NA) Plan Apo oil objective lens. Acquisition parameters were controlled by Nikon Elements, and image analysis was conducted using ImageJ or Imaris (Bitplane) software. BFA treatments (10 mg/mL) were each conducted for 1 hr at 37o C, followed by washout using pre-warmed media. Cells expressing GFP-tagged VSVG were incubated overnight at 40o C and subsequently placed into a Tokai Hit stage top incubator set to 32o C for live-cell imaging. Particle tracking, volume measurements, and linescan analysis for intensity measurements were conducted in an unbiased manner using Imaris software.

Statistical Methods {#S14}
-------------------

All p values were determined by paired t test or ANOVA, calculated using Microsoft Excel or GraphPad Prism, and data are shown as mean ± SEM. Significant differences were indicated by a p value less than 0.05.
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![The TFG (p.R106C) Mutation Alters the Conformation of TFG Ring Complexes\
(A)Cartoon highlighting the various domains of human TFG, including its PB1 domain (green), coiled-coil domain (red), disordered domain (blue), and Sec23-binding domain (purple).\
(B) Circular dichroism (CD) spectroscopy was used to characterize the N terminus of various TFG isoforms (amino acids 1--193; wild-type TFG, TFG \[p.R106C\], and TFG harboring six leucineto-valine mutations throughout its coiled-coil domain; n = 3 for each).\
(C and D) Purified recombinant isoforms of TFG (amino acids 92--138; wild-type TFG, TFG \[p.R106C\], and TFG harboring six leucine-tovaline mutations throughout its coiled-coil domain) fused to a monomeric SUMO tag were separated over a gel filtration column (Wyatt WTC-030S5) that was coupled to a multiangle light-scattering device. Eluted fractions were separated by SDS/ PAGE and stained using Coomassie Blue to highlight their elution profiles (C) (n = 3 each). Average molecular masses were calculated using ASTRA software (n = 3 each), and light-scattering profiles for each protein are shown (D).\
(E and G) Representative Kratky scattering profiles generated from the analysis of three concentrations of wild-type TFG (E) or TFG (p.R106C) (G) following SAXS (n = 3 each). All experiments were conducted in 50 mM Tris-HCl, pH 7.6, 10 mM DTT, and 100 mM NaCl.\
(F and H) Ab initio models of the N terminus (amino acids 1--138) of wild-type TFG (F) and TFG (p.R106C) (H). At least 17 structures of each protein were generated using the program DAMMIF, and dummy atom models were overlaid. The normalized spatial discrepancy (NSD) of the wild TFG SAXS envelope was 0.83, and the NSD of the TFG (p.R106C) mutant was 0.90.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0001){#F1}

![The TFG (p.R106C) Mutation Perturbs the Assembly of Compact Ring Structures\
(A and B) Recombinant wild-type TFG (A) and TFG (p.R106C) (B) were imaged by negative-staining electron microscopy following purification in 50 mM HEPES, pH 7.6, and 100 mM NaCl (n = 3 each). Montage of representative class averages (amino acids 1--193 in both cases) generated by reference-free alignment and classification are shown (right panels). Scale bars, 100 nm (left) and 5 nm (right, class averages).\
(C and D) Recombinant wild-type TFG (C) and TFG (p.R106C) (D) were imaged by negative-staining electron microscopy following purification in 50 mM MES, pH 5.5, and 100 mM NaCl (n = 3 each). Representative higher-magnification views of individual complexes are shown (right panels). Scale bars, 100 nm (left) and 25 nm (right).\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0002){#F2}

![Generation of Human iPSCs Harboring the TFG (p.R106C) Mutation\
(A)Representative Sanger sequencing traces ofTFG exon 4 from control (IMR90--4) and genome-edited (clones A, D, and G) iPSCs. The single-nucleotide change found in HSP patients is highlighted in red, while the silent mutation incorporated to enable facile identification of edited clones is highlighted in yellow.\
(B) Control iPSCs (IMR90--4 and clone G) and iPSCs harboring a mutation in TFG (clones A and D) were fixed and stained using antibodies directed against Oct4, Nanog, and SSEA4 together with Hoechst 33342 (n = 3 each). Maximum intensity projections are shown. Scale bar, 100 mm.\
(C) Giemsa banding analysis was performed oncontrol iPSCs (IMR90--4 and clone G) and iPSCs harboring a mutation in TFG (clones A and D), revealing no changes in karyotype that resulted from CRISPR-mediated genome editing.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0003){#F3}

![The TFG (p.R106C) Mutation Alters Its Distribution in a Cell-Type-Specific Manner\
(A)Representative control (IMR90--4 and clone G) and homozygous TFG (p.R106C) expressing (clone A) iPSC-derived fibroblasts were fixed and stained using antibodies directed against Sec31A (red) and TFG (green) and imaged using sweptfield confocal optics. Maximum intensity projections are shown. Scale bars, 10 mm and 1 mm (insets).\
(B) Quantification of the percentage of TFG-labeled structures that exhibit Sec31A staining in control (IMR90--4 and clone G) and homozygous TFG (p.R106C)-expressing fibroblasts (clones A, B, and C). Error bars represent mean ± SEM; n \> 10 different cells per condition; three biological replicates each. No statistically significant difference was found, as calculated using a paired t test.\
(C) Representative control (IMR90--4 and clone G) and homozygous TFG (p.R106C)-expressing (clone A) iPSC-derived melanocytes were fixed and stained using antibodies directed against Sec31A (red) and TFG (green) and imaged using swept-field confocal optics. Maximum intensity projections are shown. Scale bars, 10 mm and 1 mm (insets).\
(D) Quantification of the percentage of TFGlabeled structures that exhibit Sec31A staining in control (IMR90--4 and clone G) and homozygous TFG (p.R106C)-expressing melanocytes (clones A, B, and C). Error bars represent mean ± SEM; n \> 10 different cells per condition; three biological replicates each. \*p \< 0.05, as calculated using a paired t test.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0004){#F4}

![The TFG (p.R106C) Mutation Impairs Its Function in Differentiated Cells\
(A) Representative control (clone G) and homozygous TFG (p.R106C)-expressing (clone A) iPSC-derived melanocytes were transduced to express ts045 VSVG-GFP and imaged live using swept-field confocal optics following shift to 32C. The period of time required for VSVG-GFP to reach the perinuclear Golgi, as determined by an elevation in fluorescence intensity relative to the surrounding ER, was measured in both cases (left). Error bars represent mean ± SEM; n \> 5 different cells per condition. No statistically significant difference was found, as calculated using a paired t test. Representative linescan analyses highlight the difference in the fluorescence intensity of VSVG-GFP that accumulates in punctate structures throughout the peripheral ER, prior to its appearance in the Golgi (right; n \> 50 punctate structures per condition; five biological replicates each).\
(B) Representative images of the peripheral ER obtained using swept-fieldconfocal optics in the iPSC-derived cell lines described in (A) at various time points after shift to 32C. Scale bar, 2 mm.\
(C) Representative immunoblot analysis of extracts generated from control(clone G) and TFG (p.R106C) (clone A) iPSC-derived melanocytes using antibodies directed against phospho-IRE1 and b-actin (n = 3).\
(D) Representative control (IMR90--4 and clone G) and homozygous TFG (p.R106C)-expressing (clone A) iPSC-derived fibroblasts transfected with ManII-GFP were incubated in the presence and absence of BFA or following BFA washout. Cells were fixed under the conditions indicated and imaged using swept-field confocal optics. Maximum intensity projections are shown.Scale bar, 10 mm.\
(E and F) The distribution of ManII-GFP was quantified in control and TFG (p.R106C) iPSC-derived fibroblasts (E) and melanocytes (F) at two different time points following BFA washout. More than 100 cells were analyzed for each condition; three biological replicates each.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0005){#F5}

![The TFG (p.R106C) Mutation Leads to a Defect in Axon Fasciculation in iPSC-Derived Neurons\
(A) Representative control (clone G) and homozygous TFG (p.R106C)expressing (clone A) iPSC-derived cortical neurons were fixed and stained using antibodies directed against Sec31A (red), TFG (green), and Tau (white), and imaged using swept-field confocal optics. Maximum intensity projections are shown. Scale bars, 10 mm and 1 mm (insets).\
(B) Representative control (clone G) and homozygous TFG (p.R106C)expressing (clone A) neurospheres were plated onto glass coverslips, and axon outgrowth was examined following fixation and staining using antibodies directed against Tau after 1 week. Maximum intensity projections are shown. Scale bar, 20 mm.\
(C) Quantification of axon outgrowth observed in control (IMR90--4 and cloneG) and homozygous TFG (p.R106C)-expressing neurospheres (clones A, B, and C) 1 week after plating. Error bars represent mean ± SEM; n \> 10 neurospheres per condition; three biological replicates each. No statistically significant difference was found, as calculated using a paired t test.\
(D) Quantification of axon bundling in control (IMR90--4 and clone G), homozygous TFG (p.R106C)-expressing neurospheres (clones A, B, and C), and heterozygous SPG3A (p.P342S)-expressing neurospheres (16) 1 week after plating was calculated based on the ratio of axon thickness measured using linescan analysis at 150 mm from the edge of the neurosphere to the thickness measured 10 mm from the neurosphere. Error bars represent mean ± SEM; n \> 10 neurospheres per condition; three biological replicates each. \*\*p \< 0.01, as calculated using an ANOVA test.\
See also [Figure S5 and S6](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0006){#F6}

![The TFG (p.R106C) Mutation Leads to a Defect in L1CAM Accumulation at the Surface of Axons in iPSC-Derived Neurons\
(A) Representative control (clone G) and homozygous TFG (p.R106C)expressing (clone A) cortical neurons were grown for 16 weeks in culture and subsequently incubated live with antibodies directed against L1CAM (green). Neurons were then fixed and stained using antibodies directed against Tau (red). Maximum intensity projections are shown. Scale bars, 20 mm and 5 mm (insets).\
(B) Fluorescence intensity (I) of L1CAM relative to Tau in axons from control(clone G) and homozygous TFG (p.R106C) mutant iPSC-derived neurons. Error bars represent mean ± SEM; n \> 50 axons per condition; three biological replicates each. \*\*p \< 0.01 (compared with control), calculated using a paired t test.\
(C) Representative immunoblot analysis of control iPSC-derived neurons(clone G) and neurons harboring the homozygous TFG (p.R106C) mutation (clone A) using antibodies directed against L1CAM and b-actin. Densitometry analysis was performed to quantify changes in L1CAM levels relative to b-actin in both control and homozygous TFG (p.R106C)-expressing iPSC-derived neurons (n = 3). No statistically significant difference was found, as calculated using a paired t test.\
See also [Figure S7](#SD1){ref-type="supplementary-material"}.](nihms-1505937-f0007){#F7}

###### Highlights

-   Pathological mutations in TFG impair its ability to form compact ring complexes

-   The TFG (p.R106C) mutation compromises the kinetics of secretory protein transport

-   TFG promotes the accumulation of L1CAM at the surface of axons

-   Partial inhibition of TFG function results in a defect in axon bundling
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